1. Generics Bulletin
  2. >>Business
  3. >>Strategy

UAE’s Bioventure Is Looking For Partners To Expand

Dubai-Based Firm Has Partnered With Alvotech On MENA Biosimilars

 
• By Dave Wallace

Having recently added to its biosimilars alliance with Alvotech, Dubai-based Bioventure says it is looking to expand its international reach through further partnerships.

Handshake with world image overlaid; global partnerships concept
Bioventure is looking to expand its global reach through partnerships • Source: Shutterstock

While UAE-based firm Bioventure has already been active in striking deals for off-patent products in the Middle East and North Africa region in the few years since it was founded, the company has told Generics Bulletin that it has further ambitions to expand its international reach through partnerships with companies around the globe.

Last year, Bioventure – a subsidiary of Yas Holding’s healthcare division – was one of three firms that struck a deal with biosimilars developer Alvotech to give it rights to a

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Generics Bulletin for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Strategy

‘I’ll Be Happy When We Have 40-Plus Assets’ – Sandoz Builds Up Biosimilars

 
• By Dave Wallace

With biosimilars playing an increasingly important role in Sandoz’s business, the firm’s first-quarter results call saw management lay out the latest key developments. Meanwhile, the company also addressed the issue of US tariffs, voicing optimism over both future developments as well as its ability to weather current measures.

Teva To Slash Thousands Of Jobs And Shut More Sites Under $700m Savings Plan

 
• By Dean Rudge

Teva’s plans to generate net savings of $700m by 2027 have been described by the firm as a journey and not a destination, with the suggestion that “this era of cost efficiency, harmonization, frugality will continue.”

Tetris Deal Falls Into Place For UK’s Aspire

 
• By Dave Wallace

Niche generics company Aspire Pharma has struck a deal to acquire a portfolio of products from fellow UK firm Tetris Pharma as it is wound up, paying Tetris parent Arecor £0.5m for UK distribution rights and inventory.

Apotex Extends Formosa Ophthalmic Alliance Into Mexico

 
• By Dave Wallace

Apotex has expanded an alliance formed with Formosa in August for its novel clobetasol propionate ophthalmic treatment, adding Mexican rights to its existing deal for the Canadian market.

More from Business